Brooks Boyd Email Address

Vice President, Research and Early Development at Zogenix, Inc

Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

Pharmaceutical development executive with more than 20 years’ experience in biotechnology companies. Proven track record of development leadership and building high-performing organizations that drive successful product regulatory approvals. Motivated and creative leader with diverse experience providing leadership for both internal development projects as well as in a virtual pharmaceutical development environment. Strategic leadership responsibilities have included translational research, nonclinical development, clinical pharmacology and PK, CMC, and intellectual property.